A pancreatic cancer organoid incorporating macrophages reveals the correlation between the diversity of tumor-associated macrophages and cancer cell survival

被引:0
|
作者
Tabe, Shunsuke [1 ,2 ]
Takeuchi, Kenta [1 ]
Aoshima, Kenji [1 ]
Okumura, Ayumu [1 ]
Yamamoto, Yuya [1 ,2 ]
Yanagisawa, Kazuki [1 ]
Eto, Ryotaro [2 ]
Matsuo, Megumi [2 ,3 ]
Ueno, Yasuharu [1 ]
Konishi, Takanori [2 ]
Furukawa, Yoichi [4 ]
Yamaguchi, Kiyoshi [4 ]
Morinaga, Soichiro [5 ]
Miyagi, Yohei [6 ]
Ohtsuka, Masayuki [2 ]
Tanimizu, Naoki [1 ]
Taniguchi, Hideki [1 ,3 ]
机构
[1] Division of Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Japan
[2] Department of General Surgery, Graduate School of Medicine, Chiba University, Japan
[3] Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan
[4] Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Japan
[5] Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
[6] Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan
关键词
Brain - Cell culture - Cell proliferation - Diseases - Endothelial cells - Fibroblasts - Lung cancer - Macrophages - Stem cells;
D O I
10.1016/j.biomaterials.2024.122838
中图分类号
学科分类号
摘要
Pancreatic ductal adenocarcinoma (PDAC) is a progressive cancer with a poor prognosis. It contains a complex tumor microenvironment (TME) that includes various stromal cell types. Comprehending cellular communications within the TME is difficult due to a lack of research models that can recapitulate human PDAC-TME. Previously, we recapitulated, in part, the PDAC-TME containing a diversity of cancer-associated fibroblasts (CAFs) in vitro. This was done by establishing a PDAC organoid by co-culturing patient-derived cancer cells with human induced pluripotent stem cell (hiPSC)-derived mesenchymal and endothelial cells, which was designated the fused pancreatic cancer organoid (FPCO). We further incorporated macrophages derived from the THP-1 cell line, which are the source of tumor-associated macrophages (TAMs), a major TME component, into FPCO, which was designated M0-FPCO. Bulk RNA sequencing (RNAseq) analysis revealed that macrophages in M0-FPCO (FPCO-Mac) lost their pro-inflammatory features but acquired pro-angiogenic features. Consistently, the formation of an endothelial cell network was enhanced in M0-FPCO. Single-cell RNA-seq (scRNA-seq) analysis revealed that M0-FPCO contained five TAM subpopulations similar to the corresponding TAM in human PDAC tissue in the integrated analysis, including SPP1+-TAM, which has been correlated with tumor angiogenesis and cell proliferation. Focusing on PDAC cells, we found that they could survive longer within the organoid in the presence of TAM. Consistent with the prolonged proliferation and survival of PDAC cells, PDAC subclusters were characterized by proliferative features, such as increased M0-FPCO. Therefore, by establishing a PDAC organoid with macrophages, we recapitulated the diversity of TAMs and identified the role of TAM in endothelial network formation as well as in the modulation of PDAC cell properties. Significance: PDAC organoids, including macrophages using hiPSC, showed that PDAC-TAM has angiogenic features and contributes to PDAC cell survival. © 2024 The Authors
引用
收藏
相关论文
共 50 条
  • [31] Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer
    Ohno, S
    Ohno, Y
    Suzuki, N
    Kamei, T
    Koike, K
    Inagawa, H
    Kohchi, C
    Soma, GI
    Inoue, M
    [J]. ANTICANCER RESEARCH, 2004, 24 (5C) : 3335 - 3342
  • [32] Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer
    Ryder, Mabel
    Ghossein, Ronald A.
    Ricarte-Filho, Julio C. M.
    Knauf, Jeffrey A.
    Fagin, James A.
    [J]. ENDOCRINE-RELATED CANCER, 2008, 15 (04) : 1069 - 1074
  • [33] Tumor-associated macrophages contribute to tumor progression in ovarian cancer
    Colvin, Emily K.
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [34] Tumor-associated macrophages in cancer-related inflammation
    Mantovani, Alberto
    [J]. IMMUNOTHERAPY, 2011, 3 (04) : 21 - 22
  • [35] Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
    Gao, Jing
    Liang, Yuanzheng
    Wang, Liang
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer
    Erreni, Marco
    Mantovani, Alberto
    Allavena, Paola
    [J]. CANCER MICROENVIRONMENT, 2011, 4 (02) : 141 - 154
  • [37] Harnessing tumor-associated macrophages as aids for cancer immunotherapy
    Li, Xiaolei
    Liu, Rui
    Su, Xiao
    Pan, Yongsha
    Han, Xiaofeng
    Shao, Changshun
    Shi, Yufang
    [J]. MOLECULAR CANCER, 2019, 18 (01)
  • [38] Tumor-associated macrophages affect the treatment of lung cancer
    Yu, Zhuchen
    Zou, Juntao
    Xu, Fei
    [J]. HELIYON, 2024, 10 (07)
  • [39] Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
    Fujimura, Taku
    Kambayashi, Yumi
    Fujisawa, Yasuhiro
    Hidaka, Takanori
    Aiba, Setsuya
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [40] Arming tumor-associated macrophages to inhibit cancer progression
    Reddy, Joshua P.
    Yu, Ziqi
    Shepard, Ryan M.
    Von Schalscha, Tami
    McCormack, Stephen J.
    Weis, Sara M.
    Cheresh, David A.
    Wettersten, Hiromi I.
    [J]. CANCER RESEARCH, 2024, 84 (06)